Achieving normoglycaemia with tirzepatide: Post hoc exploratory analysis of the SURPASS J‐mono and J‐combo studies

Documenti analoghi

• Decreased fatty liver index with tirzepatide treatment in Japanese patients with type 2 diabetes: A SURPASS J‐mono post hoc analysis
  di: Masato Yoneda, et al.
  Pubblicazione: (2025)
• Correction to “Efficacy and safety in tirzepatide‐treated Korean adults with type 2 diabetes—A post hoc analysis of SURPASS‐AP‐combo and SURPASS‐3”
  Pubblicazione: (2026)
• Coronary artery disease risk prediction by combined stratification of low‐density lipoprotein‐cholesterol and high‐density lipoprotein‐cholesterol levels across different glucose statuses
  di: Junko Yachida, et al.
  Pubblicazione: (2024)
• Association of baseline characteristics with clinical outcomes of tirzepatide treatment in Japanese patients with obesity disease: A subgroup analysis of the SURMOUNT ‐J trial
  di: Koutaro Yokote, et al.
  Pubblicazione: (2025)
• Time spent in glycaemic control with sustained body weight reduction with tirzepatide: A post hoc analysis of the SURPASS clinical trial programme
  di: Brandon K. Bergman, et al.
  Pubblicazione: (2025)